Rigorous testing is crucial before making anything available to the public, but if you’re only testing a product on white people, how are you supposed to know the full spectrum of potential side effects? And why are we still qualifying this limited testing as 'rigorous'?clinical study populations by race and ethnicity in Biomedical literature
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر: